NOVARTIS logo.jpg
FDA approves Novartis Kisqali® to reduce risk of recurrence in people with HR+/HER2- early breast cancer
September 17, 2024 12:55 ET | Novartis Pharma AG
Ad hoc announcement pursuant to Art. 53 LR Broad indication in HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence approximately doubles population eligible for...
Elisa Song, MD - Tiny Health Chief Medical Officer
Tiny Health Appoints Dr. Elisa Song as Chief Medical Officer and Dr. Taylor Sittler as Board Director
September 17, 2024 09:53 ET | Tiny Health
Tiny Health appoints Dr. Elisa Song as Chief Medical Officer and Dr. Taylor Sittler as Board Director to strengthen its practitioner-focused strategy.
FSR Scientific Advisory Board Members
Foundation for Sarcoidosis Research Expands Scientific Advisory Board with 14 New Experts to Enhance Sarcoidosis Research and Patient Care
August 28, 2024 16:48 ET | Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research appoints fourteen new members to serve the organization’s Scientific Advisory Board.
Tiny Health gut microbiome test
Tiny Health and Rupa Health Team Up to Transform Preventative Care
June 26, 2024 08:30 ET | Tiny Health
Partnership expands access to comprehensive at-home microbiome testing, aiming to address health issues at the root cause
NOVARTIS logo.jpg
Novartis Phase III data confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria
May 30, 2024 18:01 ET | Novartis Pharma AG
Patients treated with remibrutinib experienced improvements in weekly urticaria activity scores (UAS7) observed as early as Week 1 and sustained to 1 year (Week 52)1Remibrutinib, an oral Bruton’s...
FINAL COALITION IMAGE
Foundation for Sarcoidosis Research Launches the Coalition for Clinical Trial Equity to Address Barriers Faced by Black Patients
May 16, 2024 17:29 ET | Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research Launches the Coalition for Clinical Trial Equity to Address Barriers Faced by Black Patients
FSR_ClevelandClinicEventPhoto
26 Patient Volunteer Leaders Attend the Foundation for Sarcoidosis Research Global Sarcoidosis Clinic Alliance Volunteer Patient Leadership Advanced Training Conference held at Cleveland Clinic
March 27, 2024 06:41 ET | Foundation for Sarcoidosis Research
26 Patient Volunteer Leaders joined the Foundation for Sarcoidosis Research at Cleveland Clinic for the Leadership Advanced Training Conference
tiny-health_press-kit-06 (1)
Tiny Health, Pioneer of the First At-Home Baby Gut Microbiome Test, Aims to Address the Pediatric Chronic Conditions Crisis
March 05, 2024 09:00 ET | Tiny Health
AUSTIN, Texas, March 05, 2024 (GLOBE NEWSWIRE) -- Tiny Health, the first at-home gut microbiome test developed for babies, today announced a $8.5 million Series A round led by Spero Ventures,...
NOVARTIS logo.jpg
Novartis presents new data on safety and efficacy of Zolgensma, including maintained and improved motor milestones in older and heavier children with SMA
March 04, 2024 01:15 ET | Novartis Pharma AG
The SMART study supplements a growing body of evidence on the use of Zolgensma in a patient population older and heavier (1.5 – 9.1 years of age) than the children treated in previous clinical studies...